A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder by Coogan, Andrew & McGowan, Niall M.
REVIEW ARTICLE
A systematic review of circadian function, chronotype
and chronotherapy in attention deficit hyperactivity disorder
Andrew N. Coogan1 • Niall M. McGowan1
Received: 17 October 2016 /Accepted: 19 December 2016 / Published online: 7 January 2017
 Springer-Verlag Wien 2017
Abstract Reports of sleep disturbances in attention deficit
hyperactivity disorder (ADHD) are common in both chil-
dren and adults; however, the aetiology of such distur-
bances is poorly understood. One potentially important
mechanism which may be implicated in disrupted sleep in
ADHD is the circadian clock, a known key regulator of the
sleep/wake cycle. In this systematic review, we analyse the
evidence for circadian rhythm changes associated with
ADHD, as well as assessing evidence for therapeutic
approaches involving the circadian clock in ADHD. We
identify 62 relevant studies involving a total of 4462
ADHD patients. We find consistent evidence indicating
that ADHD is associated with more eveningness/later
chronotype and with phase delay of circadian phase
markers such as dim light melatonin onset and delayed
sleep onset. We find that there is evidence that melatonin
treatment may be efficacious in addressing ADHD-related
sleep problems, although there are few studies to date
addressing other chronotherapeutic approaches in ADHD.
There are only a small number of genetic association
studies which report linkages between polymorphisms in
circadian clock genes and ADHD symptoms. In conclu-
sion, we find that there is consistent evidence for circadian
rhythm disruption in ADHD and that such disruption may
present a therapeutic target that future ADHD research
might concentrate explicitly on.
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Abbreviations
ADHD Attention deficit hyperactivity disorder
BD Bipolar disorder
CSM Composite scale of morningness
DLMO Dim light melatonin onset
DSPD Delayed sleep phase disorder
IS Interdaily stability
IV Intradaily variability
MEQ Morningness–eveningness questionnaire
MCTQ Munich chronotype questionnaire
MPH Methylphenidate
PER PERIOD
SOI Sleep-onset insomnia
RCT Randomised control trial
Introduction
Attention deficit hyperactivity disorder is a common con-
dition affecting in the region of 7% of children and ado-
lescents and 5% of adults (Willcutt 2012). It is
characterised by the core psychopathologies of attention
difficulties, impulsivity and hyperactivity (American Psy-
chiatric Association 2013). In children, the condition may
be diagnosed as a primarily hyperactive/impulsive subtype,
a primarily inattentive subtype, or a combined subtype
(Willcut 2012). In adults, the condition is described mostly
as a combined type (Bell 2011). ADHD is associated with
poorer psychosocial outcomes (Loe and Feldman 2007)
and shows a high frequency of comorbidity with other
psychiatric and psychological disorders (Matthews et al.
2014). The aetiology of ADHD is complex and incom-
pletely understood, although there appears to be a high
level of heritability of the condition, indicating a significant
genetic component (Matthews et al. 2014).
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A common finding in ADHD in both adults and children
is that there are significant sleep disturbances associated
with the condition (Hvolby 2015). For example, chronic
insomnia has been reported in 27% of adults with ADHD
(Schredl et al. 2007). Intriguingly, many of the core cog-
nitive and behavioural symptoms of ADHD can also be
contributed to by poor sleep quality and/or quantity
(Babkoff et al. 1991), and as such sleep disturbance may be
important in the aetiology of ADHD. In terms of the reg-
ulation of sleep, the classic two-process model (Borbe´ly
et al. 2016) proposes that sleep/wake behaviour is driven
by overlapping homeostatic processes (accumulating drive
to sleep with increasing cumulative hours of wakefulness)
and circadian drive to wakefulness (normally strong during
the day, declining moving towards the later evening). The
circadian component of this process is now known to be
determined by an endogenous circadian timekeeping
mechanism which manifests itself in a host of rhythms in
behavioural, physiological and biochemical rhythmic out-
puts recurring with periods of approximately 24 h (Butt-
gereit et al. 2015). Such outputs include diurnal rhythms in
cortisol resulting from strong circadian control of the
hypothalamic–pituitary–adrenal axis (Spiga et al. 2014)
and nocturnal secretion of the pineal hormone melatonin
gated through the suprachiasmatic nucleus (Erren and
Reiter 2015).
The clock itself is encoded at a genetic level by a
number of clock genes, whose expression leads to the
formation of a series of interlocking feedback/feedfor-
ward transcriptional loops which result in the near 24-h
expression of clock gene products, but also the rhyth-
mic expression of a large set of clock-controlled genes
across the genome (Zhang et al. 2014). From an
anatomical perspective, the master circadian clock
resides in the suprachiasmatic nuclei of the hypothala-
mus, with other clock distributed widely throughout the
brain and periphery (Mohawk et al. 2012). Given this
widespread distribution of components of the circadian
timing system, it is somewhat unsurprising that the
operation of the internal clock imposes a temporal
governance on a wide range of physiological and
molecular processes (Buijs et al. 2016) and as such are
also implicated in a wide range of diseases (Smolensky
et al. 2016). Amongst these are involvements in com-
mon psychiatric conditions such as major depression,
bipolar disorder and schizophrenia (Coogan 2013; Tam
et al. 2015; Melo et al. 2016). Given this, it is being
increasingly recognised that circadian function in these
conditions may be an appropriate target for psycho-
logical, behavioural and/or pharmacological therapies
(Dallaspezia and Benedetti 2015). Such therapies may
take advantage of fundamental knowledge of the neu-
robiology of the circadian system. For example, the
main photoreceptive system for the circadian clock is
not the visual system, but rather a system utilising the
photopigment melanopsin in a subset of light-sensitive
retinal ganglion cells (Lucas et al. 2014). It is long
known that light is the most profound influence on
circadian function and circadian clock are normally
entrained to environmental light/dark cycles (Mohawk
et al. 2012). As some psychiatric conditions, such as
bipolar disorder and seasonal affective disorder, have
been described to be associated with alterations in
circadian phase reflective of altered entrainment of the
clock to the environment, the use of timed light therapy
has been shown to be of promise in resynchronising
rhythms and improving clinical ratings (Dallaspezia and
Benedetti 2015; Lewy 2007).
Given the prevalence of sleep problems in ADHD,
recent attention has begun to focus on the role that circa-
dian dysfunction may play in such sleep problems, and
more generally how circadian dysfunction might contribute
to the aetiology and/or symptomatology of ADHD. We
have recently reviewed the mechanisms that could link
ADHD and circadian rhythm abnormalities (Coogan et al.
2016). However, to date there has been no systematic
review of the relevant literature linking circadian rhythms
and ADHD, and it is to this gap that the present study
addresses itself.
Methods
Search strategy
A structured search of PubMed, the Cochrane Library and
Clinical Trials.gov was conducted in July and September
2016 using the terms ‘‘circadian’’ OR ‘‘chronotype’’ OR
‘‘diurnal preference’’ OR ‘‘biological rhythm’’ OR ‘‘sleep’’
OR ‘‘melatonin’’ OR ‘‘light’’ AND ‘‘attention deficit
hyperactivity disorder’’ OR ‘‘ADHD’’. Publication date and
language were not restricted. Articles that focussed solely on
sleep parameters, with no measures of sleep timing or sleep/
wake cycle descriptions, or circadian or diurnal rhythms
description, were excluded, as the focus of this review is on
circadian function in ADHD. Only primary studies were
included, so reviews and meta-analyses were excluded.
Studies of neurodevelopmental disorders that did not
explicitly delineate ADHD populations were excluded.
Animal studies were also excluded. Genetic studies were
included once they included descriptions of links between
ADHD and core circadian clock genes. Interventional stud-
ies assessing impact on circadian function were included.
Studies assessing the impact of melatonin, whether used as a
somnolent or as a chronobiotic, were also included.
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Measures of circadian rhythmicity
There are a number of different measures of circadian
function that are appropriate for the assessment of circa-
dian function in clinical populations. An area that is rela-
tively accessible for examination is inter-individual
differences in sleep/wake behaviour (chronotype) and
diurnal preference for sleep/wake behaviour. These
parameters can be examined using psychometric instru-
ments for the assessment of diurnal preference, such as the
morning–eveningness questionnaire (MEQ) and the com-
posite scale of morningness (CSM). These instruments may
be described as being indicators of psychological prefer-
ence for the timing of sleep/wake behaviour, and as such
may not be fully indicative of underlying circadian phase
(Levandovski et al. 2013; Adan et al. 2012). The Munich
Chronotype Questionnaire (MCTQ) is another instrument
which records actual timing of sleep/wake behaviour, and
as such may be a truer indicator for underlying endogenous
circadian phase (Roenneberg et al. 2003). The timing of
mid-sleep on ‘‘free’’ days is taken as the key measure from
the MCTQ. The MCTQ also differentiates between ‘‘free’’
and ‘‘work’’ days, and as such allows for calculation of the
discrepancy between the timing of sleep on both work
days, a construct referred to as social jetlag (Wittmann
et al. 2006). The MEQ, CSM and MCTQ are well validated
and have been deployed in numerous studies interrogating
the epidemiology of circadian rhythmicity in humans. The
MCTQ and MEQ measures are correlated with melatonin
secretion profiles (Kantermann et al. 2015), and there is a
moderate to strong correlation between the MEQ and
MCTQ (Zavada et al. 2005).
Objective measures of sleep/wake behaviour and circa-
dian rhythms in locomotor activity include the use actig-
raphy. This approach utilises accelerometers, usually wrist-
worn, to gather data on activity patterns and from these
derive measures of circadian function as well as measures
of sleep timing and quality (Ancoli-Israel et al. 2003).
Measures of circadian rhythms often involve nonparamet-
ric analysis of circadian rhythms, yielding measures such
as relative amplitude of the rhythm (higher values indi-
cating clearer demarcation between consolidated bouts of
rest and activity), L5 and time of L5 onset (where L5 is the
activity in the least active 5 h), M10 and M10 onset
(amount of activity in the most active 10 h), and measures
of rhythm precision (interdaily stability or ‘IS’) and frag-
mentation (intradaily variability or ‘IV’; van Someren et al.
1997). Sleep parameters of interest for this review that can
be derived from actigraphy include time of bedtime, time
of sleep onset and time of wakening.
As many endocrine systems operate under profound cir-
cadian control, measures of daily variability salivary or
serum levels of hormones such as cortisol and melatonin (or
melatonin’s metabolite 6-sulfatoxymelatonin in urine) are
important indicators of circadian function. For melatonin, an
important measure is the dim lightmelatonin onset (DLMO),
which is taken as an important indicator of underlying cir-
cadian phase (Pandi-Perumal et al. 2006). On a molecular
level, the circadian clock is known to be driven by a series of
interlinked transcriptional feedback and feedforward loops
involving a panel of circadian clock genes. Expression pat-
terns of such genes can be followed in peripheral tissues such
as oral epithelia or peripheral blood mononuclear cells to
allow insight into the molecular clockwork. Polymorphisms
in clock genes have also been implicated in various neu-
ropsychiatric disorders (Landgraf et al. 2014), and as such
genetic association studies between ADHD (and ADHD
symptoms) and clock gene polymorphisms are included in
this review.
Chronotherapeutic studies
There are a number of pharmacological and non-pharma-
cological interventions that may be utilised to alter circa-
dian function, and such approaches are broadly termed
chronotherapy. Such treatments may include melatonin [in
either its application at higher doses as a somnolent, or in
smaller, time-controlled doses as a chronobiotic to alter
circadian phase (Lewy 2007)], drugs that specifically target
the circadian system [such as the antidepressant agome-
latine (San and Arranz 2008)], or environmental or beha-
vioural manipulations, such a light therapy, which alters
circadian phase and/or amplitude (Terman 2007). We
included in our review any study seeking to manipulate the
circadian system as a primary intervention.
Results and discussion
A total of 1719 articles were initially identified through
database searches. Figure 1 shows the process for article
selection. A final total of sixty-two articles were included
for review, with the oldest article included being from
2000. Overall, studies involving 33,212 participants were
included in this review. Of these, a total of 4462 ADHD
patients were studied. Of the studies included for review,
25 studies were in adult populations whilst 37 studied
children or adolescents.
Chronotype and diurnal preference in ADHD
The strongest and most consistent finding in the analysed
literature is for association of later chronotype/evening
preference with ADHD and ADHD symptoms. In total, 9
papers examining chronotype/diurnal preference were
reviewed (Table 1). Assessment of chronotype/diurnal
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preference is made through the morningness/eveningness
questionnaire (MEQ; 6 studies), the Munich Chronotype
Questionnaire (MCTQ; 4 studies), the composite scale of
morningness (CSM; 3 studies) and derivative question-
naires based on the MEQ and/or MCTQ (3 studies), with
some studies utilising overlapping measures. In studies of
ADHD adult patients, there is a remarkable agreement of
findings of later chronotype/increased eveningness in
ADHD groups compared to controls. Rybak et al. (2007)
report increased eveningness associated with increased
ADHD symptoms and poorer sustained attention on a
continuous performance task in 29 adults with ADHD. A
similar report of increased eveningness is reported in 13
adults with ADHD by Baird et al. (2012), whilst Bijlenga
et al. (2013b) report that ADHD was associated with later
mid-sleep on free days measured by the MCTQ in 202
adults with ADHD. Vogel et al. (2015) report that ADHD
was associated with later chronotype and with more
prevalent delayed sleep phase disorder and unstable timing
of meals in 202 adults with ADHD. Kooij and Bijlenga
(2014) report in a sample of 543 adults that more extreme
evening typology associates with ADHD. Similarly, Gru-
ber et al. (2012) report greater eveningness in 26 children
with ADHD, and this later diurnal preference was associ-
ated with later sleep onset.
A number of studies have examined the link between
diurnal preference/chronotype and ADHD symptoms too
using ADHD screening instruments applied to non-clinical
samples. In a cross-sectional study of 205 adults, Caci et al.
(2009) report that eveningness rated on the CSM was
associated with inattentive symptoms, more than impul-
siveness and hyperactivity. Voinescu et al. (2012) also used
the CSM in a cross-sectional study of 301 adults and report
that evening preference is associated with likely-ADHD
status and inattentive symptoms. McGowan et al. (2016)
report, using the MCTQ in a sample of 396 adults, that
social jetlag, rather than chronotype, is a predictor of
ADHD symptoms and impulsivity possibly indicating that
circadian desynchrony is an important factor mediating the
putative relationship between chronotype/circadian typol-
ogy and ADHD.
Sleep-onset insomnia and delayed sleep phase
disorder in ADHD
Delayed sleep phase disorder (DSPD) is believed to be
driven by circadian factors (Micic et al. 2016). Likewise,
sleep-onset insomnia (SOI) may have a significant circa-
dian component in its aetiology (Lack and Wright 2007).
Sixteen studies were included in this review examining
either DSPD or SOI in ADHD (Table 2). Van der Heijden
et al. (2005) report that SOI in ADHD was associated with
a phase delay of the dim light melatonin onset (DLMO)
compared to subjects with ADHD but without SOI. In this
study, 87 of 110 children with ADHD had SOI, indicating
that it is prevalent in ADHD. Van der Heijden et al. (2006)
report that sleep hygiene measures do not account for the
differences in the ADHD ? SOI group and the ADHD
alone group. Hvolby et al. (2008) report that 45 children
with ADHD had significantly longer sleep latencies, as
assessed by actigraphy, compared to both control and
children with other psychiatric diagnoses. Hoebert et al.
(2009) examined the use and discontinuation of melatonin
for SOI in ADHD in 94 children and report that melatonin
discontinuation was associated with relapse of SOI in 92%
of cases. Similar to the finding of van der Heijden et al.
(2005) in children, Van Veen et al. (2010) report that of 40
adults with ADHD studied, 31 reported SOI that was
associated with attenuated circadian rhythm amplitude of
activity and delayed DLMO. Fargason et al. (2013) on the
other hand report that in a group of 105 adults with ADHD,
circadian delay was not associated with ADHD, although
later dosing time with stimulants was associated with later
sleep times.
The role of ADHD medication in sleep-onset problems
in ADHD is indicated by the findings of Boonstra et al.
(2007) who report that in a double-blind crossover trial in
31 adults with ADHD, methylphenidate treatment was
associated with later bed times and greater sleep latency.
Likewise, Ironside et al. (2010) report that methylphenidate
treatment of 16 children with ADHD was associated with a
phase delay of the sleep/wake cycle and that methylphe-
nidate treatment was associated with an increase in motor
1,719 records idenfied:
1,288 PubMed
253 Cochrane Library
178 ClinicalTrials.gov
1,620 excluded as they contained 
no circadian measurement and/or 
intervenon, or were not in ADHD 
populaons.
99 arcles selected relang
to circadian funcon 
and/or intervenon in 
ADHD
37 arcles excluded:
1 study protocol
16 reviews
12 no circadian measures and/or 
intervenons
4 not in ADHD cohorts
4 animal studies
62 arcles on circadian 
funcon and/or intervenon 
in ADHD included for review
Fig. 1 Graphic representation of the study selection process
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activity during the sleep latency period. Interestingly,
Gruber et al. (2000) report that in an actigraphic study of
32 children with ADHD that sleep onset times are unstable,
perhaps indicating a weakened circadian component of
sleep/wake regulation.
Regarding DSPD in ADHD, there are case reports of the
condition co-occurring in ADHD (Khurshid and Khan
2009), including a striking example of seemingly complete
inversion of the sleep/wake cycle in one patient (Fargason
et al. 2013). Chiang et al. (2010) report that in a cross-
sectional study of 325 children with ADHD, the combined
subtype of ADHD was associated with circadian rhythm
sleep disorders. Sivertsen et al. (2015) report that in a
retrospective cohort of 9338 adolescents there was a
moderate association of DSPD with inattentive and
hyperactive symptoms, whilst Hysing et al. (2016) report in
a cohort of 9816 adolescents that likely-ADHD status is
associated with DSPD and later bedtimes. Bron et al.
Table 1 Summary of studies included for review which examined chronotype/diurnal preference in ADHD
Authors
and
publication
year
Study
design
Participants Paediatric,
adolescent
or adults
Circadian rhythms
measures
Intervention Summary of main results
Baird et al.
(2012)
Case–
control
study
N = 32 (13
ADHD, 19
control)
Adult Actigraphy, MEQ,
salivary cortisol and
melatonin, oral mucosa
expression of PER2 and
BMAL1
N/A ADHD was associated with loss of the
molecular rhythm of PER2 and
BMAL1 in the oral mucosa. ADHD
was also associated with greater
eveningness and a delay of the
cortisol rhythm referenced to wake
time
Bijlenga
et al.
(2013b)
Cross-
sectional
N = 391 (202
ADHD, 189
healthy control)
Adult
(19–65)
Dutch Vragenlijst
Ochtend/Avondmens
questionnaire, based on
MEQ and MCTQ;
MCTQ
N/A ADHD was associated with increased
prevalence of delayed sleep phase
disorder. ADHD was associated
with later mid-sleep on free days
Caci et al.
(2009)
Cross-
sectional
Students
(N = 205)
Adult CSM N/A Eveningness related to inattentive
symptoms of ADHD more so than
hyperactivity/impulsivity
Gruber
et al.
(2012)
Case–
control
study
N = 75 (26
ADHD, 49
healthy control)
Childhood Child morning–evening
preference scale
N/A ADHD was associated with greater
eveningness. Evening orientation
was associated with subjectively and
objectively rated sleep-onset delay
Kooij and
Bijlenga
(2014)
Cross-
sectional
N = 543 Adult Likert-like self-rating of
chronotype, self-
reported presence of
photophobia
N/A More extreme evening types
associated with ADHD; higher level
of self-reported photophobia
associated with ADHD
McGowan
et al.
(2016)
Cross-
sectional
N = 396 Adults
(mean
age = 24)
MCTQ N/A Social jetlag is a significant predictor
of ADHD symptoms and
impulsivity, chronotype is not when
social jetlag is included in the
regression model
Rybak et al.
(2007)
Cross-
sectional
ADHD (N = 29) Adult
(20–60
yrs)
MEQ N/A Later circadian preference associated
with increased self-reported
symptoms of ADHD and increased
commission errors on Conner’s
Continuous Performance Task
Vogel et al.
(2015)
Case–
control
study
ADHD
(N = 202),
obesity
(N = 114),
healthy controls
(N = 154)
Adult
(18–65
yrs)
Dutch Vragenlijst
Ochtend/Avondmens
questionnaire, based on
MEQ and MCTQ
N/A ADHD group had shorter sleep on
free days, later chronotype, more
delayed sleep phase disorder
indicators and more unstable eating
patterns than the obese group
Voinescu
et al.
(2012)
Cross-
sectional
N = 301 Adult CSM N/A ADHD symptoms are associated with
increased eveningness
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(2016) report in another retrospective cohort of adults at
risk for anxiety or depression there is an increased risk of
late chronotype and delayed sleep phase in those scoring
highly on the ADHD screener. An increased risk for
delayed sleep was also noted in a cohort study by Wyn-
chank et al. (2016).
Functional assessment of circadian rhythms
in ADHD
Twenty-two studies included in this review examined
functional circadian rhythms in ADHD (Table 3). These
rhythms include actigraphy recorded activity/rest cycles,
diurnal sampling of the hormones melatonin and cortisol,
assessment of DLMO as a circadian phase marker, patterns
of clock gene expression in accessible tissues, cognitive
assessments and physiological measures such as heart rate
variability. In a case–control study of 42 children with
ADHD, Dane et al. (2000) report that actigraphy indicates
greater afternoon, but not morning, activity in ADHD and
that there is no subtype difference between inattentive and
combined types. As noted earlier, Van der Heijden et al.
(2005, 2006) indicate that ADHD is associated with a
significant delay of DLMO. Van Veen et al. (2010) report
that in 40 adults with ADHD that there was a delay of the
diurnal cycle of activity/wake and a delayed DLMO. Baird
et al. (2012) report that in 13 adults with ADHD there was
loss of rhythmic expression of the clock genes PERIOD 2
(PER2) and BMAL1 in oral mucosa, and the period of the
actigraphic rest/activity rhythm differed significantly from
24 h. Gamble et al. report (2013) in 24 adults with ADHD
that the rest/activity cycle was delayed and that this delay
was correlated positively to the severity of the ADHD
symptoms. A case–control study of 12 adults with ADHD
reported that ADHD was associated with phase delays in
DLMO, sleep onset and core and skin temperature to
similar extents (Bijlenga et al. 2013a). Faedda et al. (2016)
report that actigraphy can reveal differences in circadian
parameters diurnal skew, L5 and relative circadian ampli-
tude that can be used to discriminate ADHD from bipolar
disorder and control in children, indicating that changes in
rest/activity patterns associated in ADHD may be different
from those associated with other psychiatric populations.
In studies which examined the daily profile in melatonin
and/or cortisol, there are more mixed findings. Daily
rhythms in salivary cortisol in 28 adults with ADHD were
examined in a case–control study, and no difference was
reported in ADHD compared to control (although there was
not a complete diurnal sampling procedure utilised in this
study, with cortisol assessment taking place at awakening,
30 min after awakening, between 17:00 and 18:00 and at
23:00; Hirvikoski et al. 2009). Personen et al. (2011) also
do not report ADHD-symptom-related changes in salivary
cortisol profiles assessed across the day in a cross-sectional
study of 322 children with ADHD. Imeraj et al. (2012a, b)
showed no differences in morning cortisol levels in 33
children with ADHD, but did note a steeper afternoon
decline of cortisol in children with ADHD and oppositional
defiant disorder. Baird et al. (2012) report a significant
delay of the cortisol diurnal rhythm relative to wakening
time in a sample of 13 adults with ADHD with 6 samples
taken across 24 h. Isaksson et al. (2015) report that in a
case–control study of 81 children with ADHD, wakening
levels of cortisol were lower in the ADHD than the control
group, and the area under the curve was also lower in the
ADHD group for the daily profile compared to controls.
With regards to melatonin, as noted above a number of
studies have reported delayed DLMO in adults and chil-
dren with ADHD (van der Heijden et al. 2005, 2006; Van
Veen et al. 2010; Bijlenga et al. 2013a). Paclt et al. (2011)
report that ADHD score correlation with melatonin levels
was dependent on symptoms of conduct disorder. In a
case–control study of 34 children with ADHD, (Nova´kova´
et al. 2011) note that ADHD is not associated with alter-
ations of the 24 h melatonin profile in the overall sample,
although older children with ADHD showed narrower
melatonin secretion profiles than controls. In their study,
Baird et al. (2012) noted a blunted melatonin rhythm in
adults with ADHD, but also noted more nocturnal light
exposure in the ADHD group which may have contributed
to acute suppression of melatonin secretion. A higher level
of serum melatonin in children with hyperactive-impulsive
ADHD with comorbid conduct disorder compared to
inattentive ADHD was noted by (Cubero-Milla´n et al.
2014) in a study of 148 children. These authors also report
that methylphenidate treatment was associated with a lower
level of the melatonin metabolite 6-sulfatoxymelatonin.
Molina-Carballo et al. (2013) report that in 226 children
with ADHD treatment with methylphenidate ablates
morning/evening differences in melatonin levels, possibly
through raising morning levels of melatonin. An increase in
urinary 6-sulfatoxymelatonin was noted in another study of
27 children and adolescents with ADHD (Bu¨ber et al.
2016). A potential involvement of pineal function and
anatomy in mediating ADHD-related changes in melatonin
is suggested by the study of Bumb et al. (2016) which
reports that ADHD was associated with lower pineal vol-
ume in a sample of 74 adults. Further, in a case report
Cunniffe et al. (2010) report that sleep/wake alterations in
an adolescent with a pineal tumour had been masked
clinically by the presence of an ADHD diagnosis, thus
highlighting the overlap of sleep/wake symptoms resulting
from ADHD or pineal dysfunction.
There are three studies included in this review which
have examined rhythms in physiological and cognitive
parameters. Imeraj et al. (2011) report that children with
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ADHD (N = 30) showed elevated heart rate, most pro-
nounced in the afternoon and the night. Buchhorn et al.
(2012) also examined diurnal changes in heart rate, and
heart rate variability, in a case–control study of 31 children
with ADHD, and report that ADHD was associated with a
marked increase in heart rate in the afternoon and less
pronounced diurnal variation in heart rate variability. Both
of these studies indicate that altered circadian function may
manifest in alterations of autonomic function relevant for
ADHD (Buijs et al. 2016; Rash et al. 2012). Impaired
sustained attention is a key cognitive dysfunction in
ADHD, one that can be assessed using objective tests of
attention and vigilance. Hunt and colleagues (2012) report
that for one such cohort, the test of variables of attention,
applied to 55 young adults with ADHD in the morning and
the late afternoon, indicates that there is no time-of-day
effect on performance on this test.
Intervention studies
Nine studies included in this review have examined the
impact of various interventions that target the circadian
system in ADHD (Table 4). The largest group of these
studies examine the impact of melatonin administration on
ADHD symptoms and other associated outcomes. Tjon Pian
Gi et al. (2003) examined the efficacy of melatonin
administration prior to bedtime in 24 children with ADHD
and insomnia in a prospective open quasi-experimental
study and report that such treatment lead to a rapid onset
decrease in sleep latency, which was significantly sustained
at three-month follow-up. Weiss et al. (2006) report that in a
randomised, double-blind crossover trial in 27 children and
adolescents with ADHD, melatonin reduced insomnia; the
largest reduction in insomnia resulted from co-administra-
tion of melatonin and a sleep hygiene intervention. Van der
Heijden et al. (2007) report results from a randomised
double-blind placebo-controlled trial of evening melatonin
for 105 children with ADHD, which indicate that melatonin
treatment resulted in advanced sleep-onset time and DLMO,
indicating an effect of melatonin on underlying delayed
circadian phase. Mohammadi et al. (2012) conducted a
randomised control trial (RCT) in 60 children with ADHD
which examined the co-administration of methylphenidate
with melatonin over a period of 8 weeks and report that
melatonin treatment was associated with shorter sleep
latency, but not with ADHD ratings. Similar decrease in
sleep latency was described in a study by Mostafavi et al.
(2012) using melatonin co-administered with methylpheni-
date, which also noted an increase in height and weight
following melatonin treatment, with no effect reported on
food intake or appetite. A long-term follow-up study by
Hoebert et al. (2009) in 94 children with ADHD and sleep-
onset insomnia indicated that melatonin discontinuation wasT
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Table 4 Summary of studies included for review which examined chronotherapeutic interventions in ADHD
Authors and
publication
year
Study design Participants Paediatric,
adolescent or
adults
Circadian rhythms
measures
Intervention Summary of main results
Furster and
Hallerba¨ck
(2015)
Register study N/A Childhood and
adolescent
Exogenous
melatonin usage
in the Swedish
Prescribed Drug
Register
N/A [50% of children and
adolescents in Sweden
using melatonin were
also using ADHD
medication. Melatonin
use is more prevalent in
boys than girls
Gruber et al.
(2007)
Case report N = 1 Child (11) Actigraphy Morning bright light
therapy
Improvement in
sustained attention and
teacher rated ADHD
score, amelioration of
delayed phase sleep
disorder following light
therapy
Hoebert et al.
(2009)
Long-term
follow-up
study
ADHD ? chronic
SOI (N = 94)
Childhood Parental
questionnaire
focusing on
melatonin use or
discontinuation
of use and
consequences for
sleep and
behaviour
N/A Long-term melatonin
treatment effective
against sleep onset
problems. Relapse of
SOI occurs when
treatment temporarily
discontinued in 92% of
children
Mohammadi
et al.
(2012)
Randomized
control trial
N = 60 Childhood
(7–12)
Subjective sleep
scoring, ADHD
ratings
Melatonin co-
administered with
methylphenidate,
8-week trial
Melatonin treatment was
associated with shorter
sleep latencies; no
changes in ADHD
ratings with melatonin
treatment
Mostafavi
et al.
(2012)
Double-blind
RCT
N = 50 Childhood
(7–12)
Subjective sleep
latency, calorific
intake,
subjective
appetite ratings,
height, weight
Melatonin co-
administered with
methylphenidate
Melatonin decreased
sleep latency and was
associated with
increased height and
weight after 8-week
melatonin treatment.
No effects on food
intake or appetite were
found
Niederhofer
(2012)
Placebo-
controlled
trial
N = 10 ADHD Adolescent
(17–19)
Wender-Utah
Questionnaire
for ADHD
Agomelatine
treatment
(4 weeks)
Agomelatine treatment
was associated with
decreased ADHD
scores across a range of
Wender-Utah subscales
compared to placebo
Tjon Pian Gi
et al.
(2003)
Prospective
open quasi-
experimental
study
ADHD with
insomnia (N =
24)
Childhood Sleep onset time Melatonin before
bed in conjunction
with normal
methylphenidate
treatment
Subjects fell asleep
significantly faster than
pre-treatment baseline.
Immediate effect
noticed in week 1 of
study and was present
after long-term follow-
up in month 3
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associated with relapse of sleep-onset insomnia in 92% of
cases. A register study in Sweden indicates that 50% of
children prescribed melatonin were also using ADHD
medications and that melatonin usage was higher in boys
than girls (Furster and Hallerba¨ck 2015).
There is little comprehensive evidence for other
chronotherapeutic approaches in ADHD. Gruber et al.
(2007) report a single case for the use of morning bright
light therapy in a child with ADHD with resulting
improvements in ADHD ratings and amelioration of
delayed phase sleep disorder. Niederhofer (2012) report
results of a small randomised placebo-controlled trial of the
use of the chronobiotic antidepressant agomelatine in 10
adolescents with ADHD which indicate that agomelatine
treatment was associated with decreased ADHD symp-
toms. Rybak et al (2006) report that morning light therapy
in adults with ADHD results in alleviation of core ADHD
symptoms, improvement of mood symptoms and advances
of circadian preference.
Genetic and environmental association studies
Five studies are included in this review that examined
association of polymorphisms in circadian clock genes
with ADHD (Table 5). Kissling et al. (2008) reported that
the T3111C single-nucleotide polymorphism (SNP) in
CLOCK is associated with ADHD symptoms in a forensic,
adult male population of 143, with the T allele conferring
risk. Xu et al. (2010) report similar results from adult
ADHD, with the T allele of the T3111C SNP in CLOCK
associated with ADHD. Jeong et al. (2014) report that the
T3111C SNP in CLOCK is also associated with ADHD
symptoms in males. Cao et al. (2012) also find that the
T3111C SNP in CLOCK is associated with ADHD in
Table 4 continued
Authors and
publication
year
Study design Participants Paediatric,
adolescent or
adults
Circadian rhythms
measures
Intervention Summary of main results
Rybak et al.
2006
Prospective
open quasi-
experimental
study
ADHD (N = 29) Adult
(18–60 years)
Morningness–
eveningness
questionnaire
(MEQ) and daily
self-report sleep/
wake diary
3-week standard
light therapy
during autumn and
winter months
Increased morningness
scores among patients
after completing LT.
Reduction in ADHD
symptom severity
indicated by Brown
Adult ADD scale and
CAARS associated with
greater MEQ scores
Van der
Heijden
et al.
(2007)
Randomized,
double-blind,
placebo-
controlled
trial
ADHD (N = 105,
medication free)
Childhood
(6–12 years)
Actigraphy-
derived sleep
onset and
DLMO
Oral administration
of 3 or 6 mg
melatonin
(depending on
body weight) or
placebo delivered
in the evening for
4 weeks
Sleep onset time
advanced with
melatonin treatment
and delayed with
placebo. DLMO
showed significant
advances in treated
group compared to
placebo group which
was significantly
delayed. No effects
noted on behaviour or
cognition
Weiss et al.
(2006)
Randomized,
double-blind,
placebo-
controlled,
crossover
trial
ADHD (N = 27,
stimulant
treated)
Childhood and
adolescent
(6–14 years)
Reduction in
initial insomnia
(sleep onset
insomnia
[60 min)
Sleep hygiene
protocol. Non-
responders treated
with 5 mg
melatonin
Significant reduction in
initial insomnia
(\60 min) in 5 cases
receiving sleep hygiene
therapy alone.
Melatonin-treated cases
showed a significant
reduction in initial
insomnia relative to
placebo. Largest effect
size noted for combined
sleep hygiene therapy
and melatonin
treatment
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children, although contrary to previous finings the authors
found in their study that the C allele confers risk. Brookes
et al. (2006) in a genome-wide study provide speculative
evidence that polymorphisms in PER 2 may be associated
with ADHD in children, but the association was not sig-
nificant at the study-wide or genome-wide level, and so this
evidence should be treated with caution. Chaste et al.
(2011) report the presence of coding mutations in the
melatonin biosynthesis pathway found in a sample of 101
adults with ADHD, but these mutations were not signifi-
cantly enriched compared to the control population.
Three studies examining the association of circadian-
relevant environmental factors with ADHD are included in
this review (Table 5). Arns et al. (2013) report that in an
analysis of records from ten countries that solar intensity is
associated with ADHD prevalence and postulate that this
may be in part due to enhanced early morning bright light
which might advance and correct otherwise delayed circa-
dian phase, whichmay be associatedwithADHD symptoms.
Arns et al. (2015) also suggest that an association noted by
Huber et al. (2015) between altitude and ADHD prevalence
may be mediated through solar intensity. Finally, in a
Table 5 Summary of studies included for review which examined circadian-related genetic and environmental associations with ADHD
Authors
and
publication
year
Study design Participants Paediatric,
adolescent or
adults
Circadian
rhythms measures
Intervention Summary of main results
Arns et al.
(2013)
Analysis of
cross-
sectional
studies
N/A Childhood,
adolescent
and adult
Solar intensity N/A An association between solar intensity
and ADHD prevalence was
described, with higher solar intensity
associated with lower prevalence.
Solar intensity predicts 34–57% of
variance n ADHD prevalence
Arns et al.
(2015)
Analysis of
cross-
sectional
studies
N/A Childhood,
adolescent
and adult
Solar intensity N/A The previously described relationship
between altitude and ADHD
prevalence (Huber et al. 2015) may
be mediated via solar intensity
Brookes
et al.
(2006)
Genome-wide
association
study
N = 1442 (674
ADHD, 808
control)
Childhood Genetic
association
N/A Speculative association of SNP in
PER2 with ADHD (not study-wide
or genome-wide significant)
Cao et al.
(2012)
Genetic
association
study
N = 316 (166
ADHD, 150
healthy control)
Childhood Genetic
association of
T3111C SNP in
CLOCK gene
with ADHD
N/A C allele of 3111 SNP in CLOCK was
associated with the ADHD group
(odds ratio 1.7)
Chaste
et al.
(2011)
Genetic
association
study
321 (101 ADHD,
220 healthy
control)
Adults Presence of
coding variants
in the melatonin
biosynthesis
pathway
N/A Non-coding mutations in melatonin
synthesis pathway were found in
ADHD, but these were not
significantly enriched compared to
controls
Jeong et al.
(2014)
Genetic
Association
Study
N = 1289 Adult CLOCK
genotype,
composite scale
of morningness
(CSM)
N/A 3111T/C SNP in CLOCK is associated
with retrospective ADHD ratings via
WURS-25; significant correlation
between CSM and WURS-25 scores
Kissling
et al.
(2008)
Candidate
gene
association
study
N = 143 adult
males
Adult CLOCK genotype N/A T-mutation of the CLOCK 3111 T/C
SNP associated with self-reported
symptoms of ADHD and diagnostic
interview
Langevin
and
Ramde´
(2012)
Case–control
study
N = 15 (10
ADHD, 5
control)
Childhood
(7–9)
Actigraphy Natural
changes in
photoperiod
Shortened photoperiod is associated
with more nocturnal agitation in
ADHD
Xu et al.
(2010)
Candidate
gene
association
study
ADHD probands
from the UK
(N = 180) and
Taiwan
(N = 212)
Childhood/
adolescent
(5–15 years)
CLOCK genotype Transmission bias of T allele of
CLOCK 3111 T/C SNP associated
with ADHD
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naturalistic study in northern latitudes, Langevin and Ramde´
(2012) find that the shortening of photoperiod in the winter is
associated with more nocturnal agitation in ten children with
ADHD studied with actigraphy.
Conclusions
This review of the literature highlights a number of striking
findings with regards to circadian function and ADHD.
First is the remarkable consensus in findings for delayed
circadian phase and later chronotype/evening preference
associated with ADHD. This level of consistency is in
contrast with the mixed picture reported for phase alter-
ations associated with different psychiatric conditions,
where a mixture of phase delays, phase advances and no
changes are reported (e.g. bipolar disorder; Melo et al.
2016). This circadian phase delay may of course be linked
to the observed link between ADHD and sleep-onset
insomnia and delayed sleep phase disorder. There appears
to be little evidence for other circadian changes in ADHD,
such as alterations in rhythm amplitude. This again is in
contrast with circadian changes associated with other
conditions such as dementia, where dampened circadian
amplitude may be the major change that occurs (Coogan
et al. 2013a, b). It is not clear why circadian rhythms show
such delays in ADHD, although the observation by Kooij
and Bijlenga (2014) of higher than expected levels of
photophobia associated with ADHD may indicate that
there is a change in the melanopsin photoreceptive system,
as this is associated with both circadian entrainment and
other non-visual responses to light including photophobia
(La Morgia et al. 2011). Future studies might address
themselves to the role of melanopsin function and circadian
entrainment explicitly in ADHD.
The presence of consistent findings of delayed circadian
rhythms in ADHD raise the possibility of chronotherapeutic
approaches to ‘‘correct’’ underlying phase alterations with a
view to increasing sleep quality/quantity and ultimately
leading to a decrease in ADHD symptoms. Such an approach
has been shown in other conditions to be of considerable
promise (e.g. Lewy et al. 2006). However, the current evi-
dence base for such approaches in ADHD is disappointingly
weak, with only one small trial of agomelatine and one case
report for light therapy assessed in the course of this review.
Thus, therewould appear to be considerable scope to develop
this avenue of investigation in future work. There is stronger
evidence of the use of melatonin in ADHD, with studies
included in this review indicating beneficial effects on sleep
but not on ADHD symptoms. It should be noted that most of
the studies examined utilised melatonin as a somnolent, and
not explicitly as a chronobiotic whose main effect would be
to advance circadian phase. Such use of melatonin requires
lower doses, but timing of dosing is vital and should be tai-
lored to the underlying circadian phase misalignment (Lewy
2007). Further, the use of the chronobiotic antidepressant
agomelatine, which is a melatoninergic agonist, should be
further explored in ADHD. There is clearly a need here for
well-designed, sufficiently powered RCTs for such inter-
ventions in ADHD, and it should be noted that recent results
of chronotherapy fromRCTs are providing promising results
(e.g. light therapy in major depression; Lam et al. 2016).
From an aetiological perspective, as there is a lack of
prospective and longitudinal studies of circadian function
in ADHD, inferences about causality of circadian dys-
function and ADHD cannot be made. Further, whilst there
are some indications that polymorphisms in clock genes
may be associated with ADHD, evidence is not strong
although there are four separate studies implicating the
CLOCK gene. Another potentially important issue on
which there appears to be too little information to make
firm conclusions is the role ADHD medication plays in
observed circadian changes in ADHD. Animal studies
indicate that stimulant and non-stimulant medications can
impact on circadian processes (e.g. Antle et al. 2012; Baird
et al. 2013; O’Keeffe et al. 2012). There are also indica-
tions that ADHD medications can impact on sleep (e.g.
Cortese et al. 2013). However, there are little explicit
analyses of ADHD medication on circadian function, and
future studies might address medicated and non-medicated
ADHD populations for circadian function in either case–
control or crossover studies.
Overall, results from this systematic review highlights a
striking commonality of findings of circadian phase delays
associated with ADHD, but also highlights the weakness of
the literature surrounding chronotherapeutic interventions
in ADHD and delineation of the aetiological significance of
circadian dysfunction in ADHD.
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